These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9863031)

  • 1. Restoration of tumour suppressor gene expression for cancer.
    Roth JA
    Forum (Genova); 1998; 8(4):368-76. PubMed ID: 9863031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 tumor suppressor gene therapy for cancer.
    Roth JA; Swisher SG; Meyn RE
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
    Edelman J; Edelman J; Nemunaitis J
    Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of adenoviral mediated p53 gene therapy for non-small cell lung cancer in Japan].
    Kagawa S; Fujiwara T; Tanaka N
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):193-7. PubMed ID: 12610865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
    Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of gene therapy for lung cancer and head and neck cancer.
    Moon C; Oh Y; Roth JA
    Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
    Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 tumor suppressor gene therapy for cancer.
    Nielsen LL; Maneval DC
    Cancer Gene Ther; 1998; 5(1):52-63. PubMed ID: 9476967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck cancer: response to p53-based therapeutics.
    Nemunaitis J; Nemunaitis J
    Head Neck; 2011 Jan; 33(1):131-4. PubMed ID: 20222046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenoviral p53 gene therapy for human lung cancer].
    Fujiwara T; Tanaka N
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular therapy in malignant tumors].
    Fey MF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1758-63. PubMed ID: 10603649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
    Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
    J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy: a molecular approach to cancer treatment.
    Anklesaria P
    Curr Opin Mol Ther; 2000 Aug; 2(4):426-32. PubMed ID: 11249773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A phase I trial of adenoviral p53 gene therapy for non-small cell lung cancer].
    Fujiwara T; Kataoka M; Kawamata O; Tanaka N
    Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):749-55. PubMed ID: 10629843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current status of gene therapy.
    Clayman GL
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizons: gene therapy for cancer.
    Baselga J
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S39-42. PubMed ID: 10630368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
    Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R
    Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.